UMass (ACC) - Hollings Cancer Center (HCC) — Worcester, Massachusetts

UMass (ACC) - Hollings Cancer Center (HCC) is a clinical research site located in Worcester, Massachusetts, United States 01655.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UMass (ACC) - Hollings Cancer Center (HCC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Glioblastoma Multiforme, Adult.

Sponsors: CNS Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UMass (ACC) - Hollings Cancer Center (HCC)?

UMass (ACC) - Hollings Cancer Center (HCC) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UMass (ACC) - Hollings Cancer Center (HCC) conducted?

UMass (ACC) - Hollings Cancer Center (HCC) has 1 clinical trials on record, with 1 currently active. Their work covers Glioblastoma Multiforme, Adult.

Is UMass (ACC) - Hollings Cancer Center (HCC) accredited by Crixeo Health?

UMass (ACC) - Hollings Cancer Center (HCC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UMass (ACC) - Hollings Cancer Center (HCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.